These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2055236)

  • 61. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antagonism of serotonin3 (5-HT3) receptors within the blood-brain barrier prevents cisplatin-induced emesis in dogs.
    Gidda JS; Evans DC; Cohen ML; Wong DT; Robertson DW; Parli CJ
    J Pharmacol Exp Ther; 1995 May; 273(2):695-701. PubMed ID: 7752072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice.
    Reith ME
    Eur J Pharmacol; 1990 Sep; 186(2-3):327-30. PubMed ID: 2289534
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emetic and antiemetic effects of opioids in the dog.
    Blancquaert JP; Lefebvre RA; Willems JL
    Eur J Pharmacol; 1986 Sep; 128(3):143-50. PubMed ID: 3024991
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.
    Young R; Johnson DN
    Pharmacol Biochem Behav; 1991 Dec; 40(4):733-7. PubMed ID: 1687761
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
    Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
    Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of tacrine and zacopride on the performance of adult rats in the working memory task.
    Jäkälä P; Sirviö J; Riekkinen PJ
    Gen Pharmacol; 1993 May; 24(3):675-9. PubMed ID: 8365650
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blockade of 5-hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat.
    Lucot JB
    Pharmacol Biochem Behav; 1989 Jan; 32(1):207-10. PubMed ID: 2734331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Cooper M; Sologuren A; Valiente R; Smith J
    Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distribution and characterisation of the [3H](S)-zacopride labelled 5-HT3 receptor in pig forebrain.
    Fletcher S; Barnes NM
    Brain Res; 1996 Aug; 729(2):281-4. PubMed ID: 8877001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 5-HT3 receptor antagonists reverse helpless behaviour in rats.
    Martin P; Gozlan H; Puech AJ
    Eur J Pharmacol; 1992 Feb; 212(1):73-8. PubMed ID: 1532555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulants.
    King FD; Hadley MS; Joiner KT; Martin RT; Sanger GJ; Smith DM; Smith GE; Smith P; Turner DH; Watts EA
    J Med Chem; 1993 Mar; 36(6):683-9. PubMed ID: 8459397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for an extra-abdominal site of action for the 5-HT3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret.
    Andrews PL; Hawthorn J
    Neuropharmacology; 1987 Sep; 26(9):1367-70. PubMed ID: 3670559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride.
    Barnes NM; Costall B; Ironside JW; Naylor RJ
    J Pharm Pharmacol; 1988 Sep; 40(9):668. PubMed ID: 2907045
    [No Abstract]   [Full Text] [Related]  

  • 80. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
    Eglen RM; Swank SR; Walsh LK; Whiting RL
    Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.